+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Psoriasis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 4911444
  • Report
  • October 2019
  • Region: Global
  • 200 pages
  • Transparency Market Research
1 of 3

FEATURED COMPANIES

  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca plc
  • Biogen, Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • MORE
Psoriasis Treatment Market - Scope of the Report

The report on the global psoriasis treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global psoriasis treatment market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast end-year. The report also provides the compound annual growth rate (CAGR) for the global psoriasis treatment market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global psoriasis treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study various phenomena in the global psoriasis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global psoriasis treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global psoriasis treatment market. The next section of the global psoriasis treatment report highlights the USPs, which include regulatory scenarios for psoriasis treatment, globally, psoriasis treatment pipeline analysis, and potential mergers & acquisition in the global psoriasis treatment market.

The report delves into the competitive landscape of the global psoriasis treatment market. Key players operating in the global psoriasis treatment market have been identified, and each one of these have been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOT are some of the attributes of the players profiled in the global psoriasis treatment market report.

Key Questions Answered in Global Psoriasis Treatment Market Report
  • What is the sales/revenue expected to be generated by psoriasis treatment products across all the regions during the forecast period?
  • What are the key trends in the psoriasis treatment market?
  • What are the major drivers, restraints, and opportunities in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue, globally, in 2027, and which product will expand at the fastest CAGR during the forecast period?
Psoriasis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global psoriasis treatment market begins with an overview of the said market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of this study, and the healthcare compliances laid down by accredited agencies in the purview of research. It is followed by market introduction, market dynamics, and an overview of the global psoriasis treatment market, which includes an’s analysis of the market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights have been provided to understand the Y-o-Y trends of the psoriasis treatment market. The next section of the global psoriasis treatment report highlights the USPs, which include regulatory scenarios for psoriasis treatment, globally, psoriasis treatment pipeline analysis, and key mergers & acquisitions in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of the key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key psoriasis treatment market manufacturers have been mapped to ascertain the size of the global psoriasis treatment market in terms of value. The forecasts presented here assess the total revenue generated in the psoriasis treatment market. In order to provide an accurate forecast, we initiated by sizing up the current psoriasis treatment market with the help of the parent market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca plc
  • Biogen, Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Psoriasis Treatment Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Psoriasis Treatment Market Analysis and Forecast, 2017-2027
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Regulatory Scenario by Region/Key Country
5.2. Psoriasis Treatment Market Pipeline Analysis
5.3. Key Mergers & Acquisitions

6. Global Psoriasis Treatment Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
6.3.1. TNF Inhibitors
6.3.2. Interleukin Inhibitors
6.3.3. Vitamin D Analogs
6.3.4. Corticosteroids
6.3.5. Others
6.4. Market Attractiveness, by Drug Class

7. Global Psoriasis Treatment Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
7.3.1. Oral
7.3.2. Parenteral
7.3.3. Topical
7.4. Market Attractiveness By Route of Administration

8. Global Psoriasis Treatment Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Others
8.4. Market Attractiveness, by Distribution Channel

9. Global Psoriasis Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Psoriasis Treatment Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region

10. North America Psoriasis Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
10.2.1. TNF Inhibitors
10.2.2. Interleukin Inhibitors
10.2.3. Vitamin D Analogs
10.2.4. Corticosteroids
10.2.5. Others
10.3. North America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
10.3.1. Oral
10.3.2. Parenteral
10.3.3. Topical
10.4. North America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Others
10.5. North America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Psoriasis Treatment Market Attractiveness Analysis
10.6.1. By Drug Class
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Psoriasis Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Others
11.2. Europe Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
11.2.1. TNF Inhibitors
11.2.2. Interleukin Inhibitors
11.2.3. Vitamin D Analogs
11.2.4. Corticosteroids
11.2.5. Others
11.3. Europe Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
11.3.1. Oral
11.3.2. Parenteral
11.3.3. Topical
11.4. Europe Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Others
11.5. Europe Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Psoriasis Treatment Market Attractiveness Analysis
11.6.1. By Drug Class
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Psoriasis Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
12.2.1. TNF Inhibitors
12.2.2. Interleukin Inhibitors
12.2.3. Vitamin D Analogs
12.2.4. Corticosteroids
12.2.5. Others
12.3. Asia Pacific Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
12.3.1. Oral
12.3.2. Parenteral
12.3.3. Topical
12.4. Asia Pacific Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Others
12.5. Asia Pacific Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Psoriasis Treatment Market Attractiveness Analysis
12.6.1. By Drug Class
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Psoriasis Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
13.2.1. TNF Inhibitors
13.2.2. Interleukin Inhibitors
13.2.3. Vitamin D Analogs
13.2.4. Corticosteroids
13.2.5. Others
13.3. Latin America Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
13.3.1. Oral
13.3.2. Parenteral
13.3.3. Topical
13.4. Latin America Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Others
13.5. Latin America Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Psoriasis Treatment Market Attractiveness Analysis
13.6.1. By Drug Class
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Psoriasis Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Drug Class, 2017-2027
14.2.1. TNF Inhibitors
14.2.2. Interleukin Inhibitors
14.2.3. Vitamin D Analogs
14.2.4. Corticosteroids
14.2.5. Others
14.3. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Route of Administration, 2017-2027
14.3.1. Oral
14.3.2. Parenteral
14.3.3. Topical
14.4. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Distribution Channel, 2017-2027
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Others
14.5. Middle East & Africa Psoriasis Treatment Market Value Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis
14.6.1. By Drug Class
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Share Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Amgen, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. Eli Lilly and Company
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Novartis AG
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. Merck & Co., Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Johnson & Johnson
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Strategic Overview
15.2.5.5. SWOT Analysis
15.2.6. Pfizer, Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. AstraZeneca plc
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. AbbVie, Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. LEO Pharma A/S
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Biogen, Inc.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen, Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Pfizer, Inc.
  • AstraZeneca plc
  • AbbVie, Inc.
  • LEO Pharma A/S
  • Biogen, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll